Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M81,452Revenue $M24,708Net Margin (%)11.4Altman Z-Score2.2
Enterprise Value $M87,982EPS $1.1Operating Margin %16.7Piotroski F-Score5
P/E(ttm)46.9Beneish M-Score-2.7Pre-tax Margin (%)12.4Higher ROA y-yY
Price/Book4.210-y EBITDA Growth Rate %4.7Quick Ratio0.7Cash flow > EarningsY
Price/Sales4.35-y EBITDA Growth Rate %-16.2Current Ratio0.8Lower Leverage y-yN
Price/Free Cash Flow44.7y-y EBITDA Growth Rate %18.0ROA % (ttm)5.0Higher Current Ratio y-yN
Dividend Yield %4.7PEG--ROE % (ttm)15.7Less Shares Outstanding y-yN
Payout Ratio %209Shares Outstanding M2,528ROIC % (ttm)15.6Gross Margin Increase y-yY

Gurus Latest Trades with AZN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AZNKen Fisher 2015-12-31 Add0.01%$30.47 - $34.77
($32.8)
$ 30.03-8%Add 692.95%221,606
AZNNWQ Managers 2015-09-30 Add0.09%$30.28 - $34.54
($32.89)
$ 30.03-9%Add 60.04%490,535
AZNMario Gabelli 2015-09-30 Sold Out $30.28 - $34.54
($32.89)
$ 30.03-9%Sold Out0
AZNKen Fisher 2015-09-30 Buy $30.28 - $34.54
($32.89)
$ 30.03-9%New holding27,947
AZNDavid Dreman 2015-06-30 Sold Out -0.16%$31.86 - $36.68
($34.23)
$ 30.03-12%Sold Out0
AZNNWQ Managers 2015-06-30 Add0.12%$31.86 - $36.68
($34.23)
$ 30.03-12%Add 486.45%306,510
AZNMario Gabelli 2015-06-30 Reduce$31.86 - $36.68
($34.23)
$ 30.03-12%Reduce -28.81%8,400
AZNNWQ Managers 2015-03-31 Reduce-0.01%$32.22 - $36.35
($34.74)
$ 30.03-14%Reduce -21.34%104,530
AZNDavid Dreman 2015-03-31 Reduce-0.01%$32.22 - $36.35
($34.74)
$ 30.03-14%Reduce -4.43%54,978
AZNMario Gabelli 2015-03-31 Reduce$32.22 - $36.35
($34.74)
$ 30.03-14%Reduce -40.70%23,600
AZNDavid Dreman 2014-12-31 Reduce-0.51%$33.58 - $37.69
($35.81)
$ 30.03-16%Reduce -75.42%57,528
AZNGeorge Soros 2014-12-31 Sold Out -0.08%$33.58 - $37.69
($35.81)
$ 30.03-16%Sold Out0
AZNMario Gabelli 2014-12-31 Reduce-0.01%$33.58 - $37.69
($35.81)
$ 30.03-16%Reduce -52.51%39,800
AZNNWQ Managers 2014-12-31 Add$33.58 - $37.69
($35.81)
$ 30.03-16%Add 3.05%132,880
AZNCharles Brandes 2014-09-30 Sold Out -0.35%$34.25 - $38.16
($36.6)
$ 30.03-18%Sold Out0
AZNDavid Dreman 2014-09-30 Reduce$34.25 - $38.16
($36.6)
$ 30.03-18%Reduce -0.70%234,006
AZNMario Gabelli 2014-09-30 Add$34.25 - $38.16
($36.6)
$ 30.03-18%Add 3.71%83,800
AZNCharles Brandes 2014-06-30 Reduce-0.78%$31.23 - $40.55
($36.09)
$ 30.03-17%Reduce -71.06%772,116
AZNDavid Dreman 2014-06-30 Reduce-0.09%$31.23 - $40.55
($36.09)
$ 30.03-17%Reduce -13.00%235,664
AZNJoel Greenblatt 2014-06-30 Sold Out -0.09%$31.23 - $40.55
($36.09)
$ 30.03-17%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AZN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AZN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ASTRAZENECA PLC10% Owner 2014-11-12Sell2,000,000$1776.65view

Quarterly/Annual Reports about AZN:

    News about AZN:

    Articles On GuruFocus.com
    Signature Select Canadian Fund Second Quarter 2015 Market Commentary Sep 22 2015 
    Francis Chou Doubles Stake in AstraZeneca Aug 11 2015 
    Last Month Insiders Bought Over $300 Million Of This Biotech Jun 26 2015 
    Guru Stocks at 52-Week Lows: XOM, WMT, CVX, AZN, COP Jun 21 2015 
    Amgen And AstraZeneca’s Deal On Psoriasis Drug Faces Termination May 27 2015 
    Johnson & Johnson A Good Investment Despite Current Lows May 14 2015 
    Vanguard Adds to Four of Its Largest Stakes May 04 2015 
    HealthCare Stocks That Can Make Investors Healthier Apr 08 2015 
    Regulus Therapeutics (RGLS) microRNA Therapeutic Milestone Payment, Dave & Buster's Entertainment (P Apr 08 2015 
    Pfizer Stocks Has A Lot Of Steam To Take The Investors Higher Jan 20 2015 

    More From Other Websites
    AstraZeneca Tops Q4 Earnings, Falls on Bleak 2016 Outlook Feb 05 2016
    Can AstraZeneca plc, Prudential plc & Rolls-Royce Holding PLC Escape Their Month Of Misery? Feb 05 2016
    Can AstraZeneca plc, Prudential plc & Rolls-Royce Holding PLC Escape Their Month Of Misery? Feb 05 2016
    Friday newspaper share tips: AstraZeneca at least worth holding on to Feb 05 2016
    Questor share tip: AstraZeneca faces Crestor crunch in year ahead Feb 05 2016
    Allstate and CBS are big market movers Feb 04 2016
    Europe close: Shares rise as oil strengthens and US dollar weakens Feb 04 2016
    Britain's FTSE 100 gets boost after weak dollar helps commodities Feb 04 2016
    Weak dollar pummels European markets Feb 04 2016
    AstraZeneca warns of lower profits as generic competition grows Feb 04 2016
    Britain's FTSE 100 gets boost after weak dollar helps commodities Feb 04 2016
    Here’s Why AstraZeneca (AZN) Stock is Dropping Today Feb 04 2016
    Results round-up Feb 04 2016
    AstraZeneca CEO open for deals that pay from day one Feb 04 2016
    [$$] AstraZeneca Shares Slip After Earnings Warning Feb 04 2016
    AstraZeneca Falls More Than 5% Following Q4 Print Feb 04 2016
    AstraZeneca CEO Raises Bar for Deals After Acquisitions Spree Feb 04 2016
    Britain's FTSE 100 gets boost after weak dollar helps commodities Feb 04 2016
    AstraZeneca doubles profits, warns of lower drug sales Feb 04 2016
    Is AstraZeneca plc A Buy After This Week’s Results? Feb 04 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK